Getting Treatment Right Prevention and Treatment of Venous Thromboembolism (VTE)

Course overview

Venous thromboembolism (VTE) is among the leading causes of death from cardiovascular disease. The spectrum of VTE presentations ranges, by degree of severity, from deep vein thrombosis to acute pulmonary thromboembolism. Since 2009 four DOACs have been FDA approved for these indications, and their use is wide-spread, it is challenging to ensure patient safety as each agent has slightly different pharmacokinetic considerations with its use. Certain clinical situations may favor one DOAC over another. This program will focus on the prevention and treatment of venous thromboembolism (VTE) and address safety and efficacy with each agent, initial recommendations for dosing and adjustments based on renal considerations, drug interactions, and age and weight. Common risk factors for bleeding will be identified as well as options in support of the management of bleeding, if it should occur, are proposed.